Efficacy and Cost of State Quitline Policies

NCT00366977 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 4614

Last updated 2011-05-02

No results posted yet for this study

Summary

State-sponsored anti-tobacco campaigns are motivating large numbers of smokers to seek advice, assistance, and support to make their cessation efforts more successful. Like many states, Oregon has sponsored the implementation of a statewide telephone quitline to provide information, referrals, and cessation support for callers. This study will answer key policy questions about how to most effectively support smokers who call the Oregon Quitline for assistance. The specific aims are to recruit 4,500 callers to participate in a 3 x 2 randomized trial comparing the cost and cost effectiveness of three levels of behavioral intervention. We will also test two different policies on the availability of nicotine patch therapy. Subjects will be interviewed by telephone at 6 and 12 months to assess smoking status, quit attempts, and use of health plan anc community cessation services. Costs will be assessed separately from the perspectives of the patients, health plans, the State (i.e., Oregon Quitline), and society. Cost per quit and cost per year quality-adjusted years of life saved will be calculated from each of these perspectives.

Conditions

  • Smoking Cessation
  • Tobacco Use Cessation
  • Cost-effectiveness

Interventions

BEHAVIORAL

Multi-session telephone counseling

DRUG

NRT patches

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Department of Human Services, Oregon

    collaborator OTHER_GOV
  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Jack F. Hollis, PhD · Kaiser Permanente Foundation Hospitals/Center for Health Research

  • Timothy A McAfee, MD · Group Health Center for Health Promotion

  • Michael J Stark, PhD · Oregon Health Division/Center for Disease Prevention Epidemiology

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-06-30
Primary Completion
2005-01-31
Completion
2005-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00366977 on ClinicalTrials.gov